Institutional investors purchased a net $2.9 million shares of NVO during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 9.90% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBIA MANAGEMENT INVESTMENT A... Bought 3.2 Million shares of Novo Nordisk
ARROWSTREET CAPITAL LP Bought 2.3 Million shares of Novo Nordisk
WCM INVESTMENT MANAGEMENT Bought 2.0 Million shares of Novo Nordisk